138 related articles for article (PubMed ID: 560302)
21. A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.
McLaughlin AP; Brooks JD
J Urol; 1974 Sep; 112(3):366-72. PubMed ID: 4546711
[No Abstract] [Full Text] [Related]
22. Immunobiology of genitourinary tumors.
Lange PH; Hakala TR; Fraley EE
Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
[No Abstract] [Full Text] [Related]
23. [6 cases of second primary neoplasms].
Ardiles A; Aldunate C; Lagos M; Larraín P; Martínez C; Olivares R
Rev Med Chil; 1990 Nov; 118(11):1291-3. PubMed ID: 1967110
[No Abstract] [Full Text] [Related]
24. [Immunotherapy in uropathology].
Verkarre V; Roussel H; Granier C; Tartour E; Allory Y
Ann Pathol; 2017 Feb; 37(1):90-100. PubMed ID: 28111042
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
[TBL] [Abstract][Full Text] [Related]
26. [Value of alpha-globulin as a biological tracer in urogenital cancer].
Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
Actas Urol Esp; 1978; 2(3):119-26. PubMed ID: 79304
[No Abstract] [Full Text] [Related]
27. The effects of treatment on delayed cutaneous hypersensitivity responses (DNCB, croton oil, and recall antigen) in patients with genitourinary cancer.
Elhilali MM; Brosman SA; Vescera C; Paul JG; Fahey JL
Cancer; 1978 May; 41(5):1765-70. PubMed ID: 647626
[No Abstract] [Full Text] [Related]
28. Lymphocyte stimulation in urologic cancer patients.
Catalona WJ; Tarpley JL; Chretien PB; Castle JR
J Urol; 1974 Sep; 112(3):373-7. PubMed ID: 4859402
[No Abstract] [Full Text] [Related]
29. Carcinoembryonic antigen and urothelial carcinoma.
Hall RR; Laurence DJ; Neville AM; Wallace DM
Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
[No Abstract] [Full Text] [Related]
30. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
31. The occurrence of SV40-Neutralizing antibodies in sera of patients with genitourinary carcinoma.
Shah KV; Palma LD; Murphy GP
J Surg Oncol; 1971; 3(4):443-50. PubMed ID: 4329010
[No Abstract] [Full Text] [Related]
32. [Value of alpha-2 globulin, as a biological tracer in the urothelial carcinoma].
Gastón de Iriarte E; López-García JA; Hidalgo L; Mendoza M; Martínez-Piñeiro JA
Arch Esp Urol; 1978; 31(3):225-34. PubMed ID: 80976
[TBL] [Abstract][Full Text] [Related]
33. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
[No Abstract] [Full Text] [Related]
34. Impaired cytokine production in whole blood cell cultures of patients with urological carcinomas.
Elsässer-Beile U; von Kleist S; Fischer R; Martin M; Wetterauer U; Gallati H; Mönting JS
J Cancer Res Clin Oncol; 1993; 119(7):430-3. PubMed ID: 8491765
[TBL] [Abstract][Full Text] [Related]
35. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes of urologic cancer patients.
Catalona WJ; Ratliff TL; McCool RE
J Natl Cancer Inst; 1980 Sep; 65(3):553-7. PubMed ID: 6157855
[TBL] [Abstract][Full Text] [Related]
36. [Lymph node extensions of urogenital cancers in men (use of lymphography apropos of 73 cases)].
Abbes M; Juillard G; Giraud C
J Urol Nephrol (Paris); 1967; 73(7):547-56. PubMed ID: 4293331
[No Abstract] [Full Text] [Related]
37. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
[No Abstract] [Full Text] [Related]
38. [Early detection of urogenital cancers: kidney, bladder, prostatic and testicular cancers].
Kawai T; Yamauchi T; Tachibana Y; Yoshino S; Kokuho M
Gan No Rinsho; 1988 Aug; 34(10):1403-7. PubMed ID: 3172497
[TBL] [Abstract][Full Text] [Related]
39. Referral pattern of urological malignancy in Indonesia.
Sugandi S
Br J Urol; 1989 Jan; 63(1):1-3. PubMed ID: 2537672
[TBL] [Abstract][Full Text] [Related]
40. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C
J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
